MARKET

PULM

PULM

Pulmatrix
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.150
+0.080
+7.48%
After Hours: 1.150 0 0.00% 17:57 03/27 EDT
OPEN
1.120
PREV CLOSE
1.070
HIGH
1.200
LOW
1.050
VOLUME
684.88K
TURNOVER
--
52 WEEK HIGH
3.010
52 WEEK LOW
0.6103
MARKET CAP
22.99M
P/E (TTM)
-0.5238
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of PULM and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average PULM stock price target is 10.00 with a high estimate of 10.00 and a low estimate of 10.00.

EPS

PULM News

More
  • Pulmatrix EPS misses by $0.34, beats on revenue
  • seekingalpha · 1d ago
  • Pulmatrix Reports 2019 Financial Results and Provides Business Update
  • PR Newswire · 1d ago
  • TSLA, TWTR among premarket gainers
  • Seeking Alpha - Article · 03/02 14:16
  • The Wining Sector & Its Top Stocks in Virus-Infected January
  • Zacks · 01/31 12:20

Industry

Biotechnology & Medical Research
-2.43%
Pharmaceuticals & Medical Research
-0.87%

Hot Stocks

Symbol
Price
%Change

About PULM

Pulmatrix, Inc. is a clinical stage biopharmaceutical company developing inhaled therapies to address serious pulmonary disease. The Company’s product pipeline is focused on advancing treatments for rare diseases, including PUR1900, an inhaled anti-fungal for patients with lung disease, including cystic fibrosis. In addition, the Company focuses on pulmonary diseases through collaboration with partners, including PUR0200, a generic in clinical development for chronic obstructive pulmonary disease.
More

Webull offers kinds of Pulmatrix Inc stock information, including NASDAQ:PULM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PULM stock news, and many more online research tools to help you make informed decisions.